CDKN2A and melanoma: A combination of three polymorphism of CDKN2A spanning the coding exon 1a (rs2811710), the first intron (rs2518720), and the 5′ regulatory region (rs2811708) was also reported significantly associated with decreased OS in melanoma [37].